Literature DB >> 10615219

Cholesterol reduction using manufactured foods high in monounsaturated fatty acids: a randomized crossover study.

C M Williams1, J A Francis-Knapper, D Webb, C A Brookes, A Zampelas, J A Tredger, J Wright, G Meijer, P C Calder, P Yaqoob, H Roche, M J Gibney.   

Abstract

In two separate studies, the cholesterol-lowering efficacy of a diet high in monounsaturated fatty acids (MUFA) was evaluated by means of a randomized crossover trial. In both studies subjects were randomized to receive either a high-MUFA diet or the control diet first, which they followed for a period of 8 weeks; following a washout period of 4-6 weeks they were transferred onto the opposing diet for a further period of 8 weeks. In one study subjects were healthy middle-aged men (n 30), and in the other they were young men (n 23) with a family history of CHD recruited from two centres (Guildford and Dublin). The two studies were conducted over the same time period using identical foods and study designs. Subjects consumed 38% energy as fat, with 18% energy as MUFA and 10% as saturated fatty acids (MUFA diet), or 13% energy as MUFA and 16% as saturated fatty acids (control diet). The polyunsaturated fatty acid content of each diet was 7%. The diets were achieved by providing subjects with manufactured foods such as spreads, 'ready meals', biscuits, puddings and breads, which, apart from their fatty acid compositions, were identical for both diets. Subjects were blind to which of the diets they were following on both arms of the study. Weight changes on the diets were less than 1 kg. In the groups combined (n 53) mean total and LDL-cholesterol levels were significantly lower at the end of the MUFA diet than the control diet by 0.29 (SD 0.61) mmol/l (P < 0.001) and 0.38 (SD 0.64) mmol/l (P < 0.0001) respectively. In middle-aged men these differences were due to a mean reduction in LDL-cholesterol of -11 (SD 12)% on the MUFA diet with no change on the control diet (-1.1 (SD 10)%). In young men the differences were due to an increase in LDL-cholesterol concentration on the control diet of +6.2 (SD 13)% and a decrease on the MUFA diet of -7.8 (SD 20)%. Differences in the responses of middle-aged and young men to the two diets did not appear to be due to differences in their habitual baseline diets which were generally similar, but appeared to reflect the lower baseline cholesterol concentrations in the younger men. There was a moderately strong and statistically significant inverse correlation between the change in LDL-cholesterol concentration on each diet and the baseline fasting LDL-cholesterol concentration (r -0.49; P < 0.0005). In conclusion, diets in which saturated fat is partially replaced by MUFA can achieve significant reductions in total and LDL-cholesterol concentrations, even when total fat and energy intakes are maintained. The dietary approach used to alter fatty acid intakes would be appropriate for achieving reductions in saturated fat intakes in whole populations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10615219

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  3 in total

1.  DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial.

Authors:  Peter J H Jones; Vijitha K Senanayake; Shuaihua Pu; David J A Jenkins; Philip W Connelly; Benoît Lamarche; Patrick Couture; Amélie Charest; Lisa Baril-Gravel; Sheila G West; Xiaoran Liu; Jennifer A Fleming; Cindy E McCrea; Penny M Kris-Etherton
Journal:  Am J Clin Nutr       Date:  2014-05-14       Impact factor: 7.045

2.  Successful manipulation of the quality and quantity of fat and carbohydrate consumed by free-living individuals using a food exchange model.

Authors:  Carmel Moore; Rachel Gitau; Louise Goff; Fiona J Lewis; Margaret D Griffin; Mark D Chatfield; Susan A Jebb; Gary S Frost; Tom A B Sanders; Bruce A Griffin; Julie A Lovegrove
Journal:  J Nutr       Date:  2009-06-23       Impact factor: 4.798

3.  Argan oil prevents prothrombotic complications by lowering lipid levels and platelet aggregation, enhancing oxidative status in dyslipidemic patients from the area of Rabat (Morocco).

Authors:  Adil Haimeur; Hafida Messaouri; Lionel Ulmann; Virginie Mimouni; Azelarab Masrar; Abdelmjid Chraibi; Gérard Tremblin; Nadia Meskini
Journal:  Lipids Health Dis       Date:  2013-07-20       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.